USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS. Mediterr J Hematol Infect Dis 2010, 2 (1), e2010003. https://doi.org/10.4084/mjhid.2010.003.